Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Lung Neoplasms 4Anemia 4Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Pleural Effusion 1Neutropenia 1Multiple Myeloma 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Thoracoscopy 4vandetanib 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Thoracentesis 1Tenecteplase 1Surgical Procedures, Operative 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Catheters, Indwelling 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion × Darbepoetin alfa × Thoracic × Clear all
NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Amgen

Phase 3 Terminated
2,549 enrolled 19 charts
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡